Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.78Price to Book
VS
Market
Sector
Industry
History
$ 4.15Close
$ 4.15 - $ 16.1 52-Week Range
Ticker Information
Ticker
DRMACompany Name
DERMATA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDERMATA THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
DRMA - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 5.61M | $ 4.39M | 0.78 |
| 3/31/2025 | $ 7.3M | $ 4.97M | 0.68 |
| 12/31/2024 | $ 1.56M | $ 6.35M | 4.07 |
| 9/30/2024 | $ 4.74M | $ 2.51M | 0.53 |
| 6/30/2024 | $ 3.32M | $ 3.07M | 0.92 |
| 3/31/2024 | $ 3.81M | $ 2.2M | 0.58 |
| 12/31/2023 | $ 6.36M | $ 2.66M | 0.42 |
| 9/30/2023 | $ 6.41M | $ 2.49M | 0.39 |
| 6/30/2023 | $ 8.03M | $ 3.7M | 0.46 |
| 3/31/2023 | $ 8.09M | $ 4.51M | 0.56 |
Key Performance Insights, Last 5 Years
- DERMATA THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, DERMATA THERAPEUTICS INC's average P/B has been 1.06.
- The median P/B for DERMATA THERAPEUTICS INC during this period was 0.7
- DERMATA THERAPEUTICS INC reached its highest P/B over the past 5 years at 4.07.
- The lowest P/B recorded by DERMATA THERAPEUTICS INC in the same timeframe 0.39
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for DERMATA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ -3.18M ]
(=) P/B [ 0 ] DRMA - Price to Book, Last 5 years
0.39
Minimum
Sep 30, 2023
4.07
Maximum
Dec 31, 2024
1.06
Average
0.7
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |